Stephan, R., Ghofrani, H., Beghetti, M., Ivy, D., Fritsch, A., Weimann, G., . . . Frey, R. (2015). Riociguat for pulmonary arterial hypertension (PAH) associated with congenital heart disease (CHD): A subgroup analysis from the PATENT studies. BMC Pharmacol Toxicol.

Stephan, Rosenkranz, Hossein-Ardeschir Ghofrani, Maurice Beghetti, Dunbar Ivy, Arno Fritsch, Gerrit Weimann, Soundos Saleh, Christian Apitz, i Reiner Frey. "Riociguat for Pulmonary Arterial Hypertension (PAH) Associated With Congenital Heart Disease (CHD): A Subgroup Analysis From the PATENT Studies." BMC Pharmacol Toxicol 2015.

Stephan, Rosenkranz, et al. "Riociguat for Pulmonary Arterial Hypertension (PAH) Associated With Congenital Heart Disease (CHD): A Subgroup Analysis From the PATENT Studies." BMC Pharmacol Toxicol 2015.